The Middle East and Africa Non-Vascular Stents market size was around USD 41.18 million in 2023. It is expected to grow at a CAGR of 5.8% to reach USD 54.60 by 2028. It captures 4% of the global market.
Growing demand for minimally invasive techniques and the rise in the geriatric population and growing awareness over the availability of different treatment procedures are likely to bolster the need of the market. The increasing number of hospitals and healthcare centers is also propelling the growth rate of the market. The aging population is expected to reach 2 billion by 2050, as per World Health Organization (WHO). An increase in per head income also fuels the market growth in the region.
Strict regulatory bodies and irregular productivity are limiting the market growth in MEA. The cost of the treatment procedures and the paid excise taxes on medical devices is very high, impeding the non-vascular stents market growth in the Middle East & Africa region.
This research report on the Middle East and Africa Non-Vascular Stents Market has been segmented and sub-segmented into the following categories:
By End User:
The Middle East & Africa solid tumor market is projected to have a minimal share in the global market and maintains its share throughout the assessment period. The region is accounted to hold only 4% of the non-vascular stents market over the period. The quick surge in technological advancements in the healthcare domain and growing regular diseases like cancer, urolithiasis, and more are the factors responsible for market growth. Soaring huge investments and funds for research and development in developing superior stents and raw materials escorted with less invasive stenting techniques is spurring the non-vascular stents market growth. South Africa is leading the market with a maximum share in the region over the period. Escalating life span and development in expenses made by the local governments in healthcare elevate market growth. Increasing demand for non-vascular stents due to a surge in regular chronic obstructive pulmonary disorders (COPD), chronic pancreatitis, prostate cancer, and glaucoma drives the market further. GCC and other countries of MEA are likely to have substantial growth in the market throughout the analysis period.
Key market participants in the MEA Non-Vascular Stents Market include CONMED Corporation. Other players in the market include Taewoong Medical Co., Medtronic; C. R. Bard, Inc.; Boston Scientific Corporation; HOBBS MEDICAL, INC; Cook Medical; ELLA - CS, s.r.o.; Ltd.; Synchron Med Inc.; and Glaukos Corporation.
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: [email protected]